Legis Daily

COVID Act of 2022

USA117th CongressS-3463| Senate 
| Updated: 1/18/2022
Marco Rubio

Marco Rubio

Republican Senator

Florida

Cosponsors (19)
Tommy Tuberville (Republican)Rick Scott (Republican)Mike Braun (Republican)Roger Marshall (Republican)Thomas Tillis (Republican)Cindy Hyde-Smith (Republican)Cynthia M. Lummis (Republican)Marsha Blackburn (Republican)Roger F. Wicker (Republican)Tim Scott (Republican)Ben Sasse (Republican)Kevin Cramer (Republican)James Lankford (Republican)John Kennedy (Republican)Bill Hagerty (Republican)John Cornyn (Republican)Chuck Grassley (Republican)Steve Daines (Republican)John Hoeven (Republican)
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Coronavirus Origin Validation, Investigation, and Determination Act of 2022 or the COVID Act of 2022 This bill requires the President to impose sanctions and take other actions related to COVID-19 if certain conditions are not met. Specifically, if the President is unable to certify within 90 days of this bill's enactment that China's government has allowed a transparent international forensic investigation into the origins of COVID-19 and certain laboratories in the city of Wuhan, the President must impose visa- and property-blocking sanctions against (1) individuals with leadership positions in the Chinese Academy of Sciences (CAS); and (2) officials of the Chinese Communist Party, China's military, or China's State Council who were involved in concealing or restricting information about the initial COVID-19 outbreak in China. If the certification cannot be made, the President must also (1) prohibit federal funding for collaborative projects between U.S.-based researchers and CAS researchers in any academic field, and (2) prohibit U.S.-based researchers and institutions that receive federal funding from engaging in certain research on viruses with individuals or institutions based in China.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 10, 2022
Introduced in Senate
Jan 10, 2022
Introduced in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.
Jan 18, 2022
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 243.
  • January 10, 2022
    Introduced in Senate


  • January 10, 2022
    Introduced in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.


  • January 18, 2022
    Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 243.

International Affairs

Related Bills

  • HR 117-4048: COVID–19 Origins Accountability Act of 2021
  • S 117-2148: COVID Act of 2021
AsiaAustraliaCardiovascular and respiratory healthCell biology and embryologyChinaDiplomacy, foreign officials, Americans abroadEmergency medical services and trauma careEuropeForeign propertyFranceGeneticsGermanyGovernment studies and investigationsHealth facilities and institutionsHealth information and medical recordsIndiaInfectious and parasitic diseasesInternational organizations and cooperationJapanMedical researchMedical tests and diagnostic methodsNetherlandsOceaniaPolitical parties and affiliationPresidents and presidential powers, Vice PresidentsResearch administration and fundingSanctionsUnited KingdomVisas and passportsWar and emergency powers

COVID Act of 2022

USA117th CongressS-3463| Senate 
| Updated: 1/18/2022
Coronavirus Origin Validation, Investigation, and Determination Act of 2022 or the COVID Act of 2022 This bill requires the President to impose sanctions and take other actions related to COVID-19 if certain conditions are not met. Specifically, if the President is unable to certify within 90 days of this bill's enactment that China's government has allowed a transparent international forensic investigation into the origins of COVID-19 and certain laboratories in the city of Wuhan, the President must impose visa- and property-blocking sanctions against (1) individuals with leadership positions in the Chinese Academy of Sciences (CAS); and (2) officials of the Chinese Communist Party, China's military, or China's State Council who were involved in concealing or restricting information about the initial COVID-19 outbreak in China. If the certification cannot be made, the President must also (1) prohibit federal funding for collaborative projects between U.S.-based researchers and CAS researchers in any academic field, and (2) prohibit U.S.-based researchers and institutions that receive federal funding from engaging in certain research on viruses with individuals or institutions based in China.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 10, 2022
Introduced in Senate
Jan 10, 2022
Introduced in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.
Jan 18, 2022
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 243.
  • January 10, 2022
    Introduced in Senate


  • January 10, 2022
    Introduced in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.


  • January 18, 2022
    Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 243.
Marco Rubio

Marco Rubio

Republican Senator

Florida

Cosponsors (19)
Tommy Tuberville (Republican)Rick Scott (Republican)Mike Braun (Republican)Roger Marshall (Republican)Thomas Tillis (Republican)Cindy Hyde-Smith (Republican)Cynthia M. Lummis (Republican)Marsha Blackburn (Republican)Roger F. Wicker (Republican)Tim Scott (Republican)Ben Sasse (Republican)Kevin Cramer (Republican)James Lankford (Republican)John Kennedy (Republican)Bill Hagerty (Republican)John Cornyn (Republican)Chuck Grassley (Republican)Steve Daines (Republican)John Hoeven (Republican)

International Affairs

Related Bills

  • HR 117-4048: COVID–19 Origins Accountability Act of 2021
  • S 117-2148: COVID Act of 2021
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
AsiaAustraliaCardiovascular and respiratory healthCell biology and embryologyChinaDiplomacy, foreign officials, Americans abroadEmergency medical services and trauma careEuropeForeign propertyFranceGeneticsGermanyGovernment studies and investigationsHealth facilities and institutionsHealth information and medical recordsIndiaInfectious and parasitic diseasesInternational organizations and cooperationJapanMedical researchMedical tests and diagnostic methodsNetherlandsOceaniaPolitical parties and affiliationPresidents and presidential powers, Vice PresidentsResearch administration and fundingSanctionsUnited KingdomVisas and passportsWar and emergency powers